Lexicon Pharmaceuticals (LXRX) Total Debt: 2009-2012
Historic Total Debt for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $23.8 million.
- Lexicon Pharmaceuticals' Total Debt fell 5.60% to $23.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $23.8 million, marking a year-over-year decrease of 5.60%. This contributed to the annual value of $24.9 million for FY2011, which is 12.60% down from last year.
- Per Lexicon Pharmaceuticals' latest filing, its Total Debt stood at $23.8 million for Q3 2012, which was down 1.50% from $24.2 million recorded in Q2 2012.
- In the past 5 years, Lexicon Pharmaceuticals' Total Debt ranged from a high of $67.6 million in Q3 2009 and a low of $23.8 million during Q3 2012.
- Moreover, its 3-year median value for Total Debt was $25.6 million (2011), whereas its average is $31.2 million.
- Data for Lexicon Pharmaceuticals' Total Debt shows a peak YoY increase of 44.24% (in 2010) and a maximum YoY decrease of 57.47% (in 2010) over the last 5 years.
- Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Total Debt stood at $67.0 million in 2009, then slumped by 57.47% to $28.5 million in 2010, then dropped by 12.60% to $24.9 million in 2011, then decreased by 5.60% to $23.8 million in 2012.
- Its last three reported values are $23.8 million in Q3 2012, $24.2 million for Q2 2012, and $24.5 million during Q1 2012.